Case Study  ·  Voice of the Customer

Asking surgeons about antibiotic bone fillers.

A global medical device company wanted to know if surgeons would value bone void fillers preloaded with antibiotics. We interviewed 31 clinicians across 6 specialties to test the need, interest and conditions for use.

The Client

The client is a global medical device company. It was running an infection control initiative across 5 product areas.

The Challenge

Add antibiotics?
Ask the surgeons.

Prescouter was asked to investigate the potential benefit and added convenience of adding antimicrobials to existing bone void filling products, as part of the client’s infection control initiative.

  • Need

    Clinical need

    Where infection risk drives demand.

  • Interest

    Surgeon willingness

    Who would use it, and when.

  • Product

    Preferred antibiotics

    Which drugs and patients fit best.

Our Approach

Listening to the people who use it routinely.

Clinician interviews
31clinicians interviewed

Talk to users

We spoke with clinicians who routinely use bone void fillers about their needs and interest.

Specialty mix
6areas of expertise

Cover every angle

Interviews spanned trauma, orthopedic, foot and ankle, podiatric and joint reconstructive surgery.

Rolling insight
Matrixof interview findings

Share as you go

Partial findings came at every meeting, ending in a report and an easy-to-read interview matrix.

The Outcome

Real surgeon insight behind the product.

Prescouter gathered real-world views from 31 clinicians on the need for antimicrobial bone void fillers. The findings showed market potential, preferred antibiotics, the patient groups most likely to benefit and the conditions under which surgeons would use the product.

  • Market

    Market potential

    Grounded in clinician demand.

  • Drugs

    Preferred antibiotics

    Named by the surgeons themselves.

  • Patients

    Priority cohorts

    Patients who benefit most.

Product ideas that sound convenient still need clinical buy-in. Talking to routine users early shows what will actually be adopted.

Let’s Talk

What would your users tell you today?

Talk to the clinicians who matter and build what they will use. Wherever you’re starting from, we’ll help you get there.

Or email [email protected]

Book a Session

Want to skip the email back-and-forth?

Pick a time on our calendar right now.

If you’d like to know the outcome of your submission, please leave your email address